Healthy Returns: How competitive can Roche be in the weight loss drug market?
Roche presented early-stage data on its obesity injection and pill at EASD. Meanwhile, Oura enters into metabolic health market with acquisition of Veri.
| Ticker |
Sentiment |
Impact |
|
DXCM
|
Neutral
|
3 %
|
|
NVO
|
Somewhat Bullish
|
3 %
|
